rhagic stroke (HS) and ischemic stroke (IS). There were marked differences in the fraction of death assigned to IS and HS for unspecified stroke and hypertension between GBD regions and between age groups. Conclusions: A large proportion of stroke fatalities are derived from the redistribution of 'unspecified stroke' and 'hypertension' with marked regional differences. Future advancements in stroke certification, data collections and statistical analyses may improve the estimation of the global stroke burden.
Introduction
The Global Burden of Diseases (GBD) 2013 results have confirmed that stroke remains a leading cause of mortality and disability-adjusted life years [1] . These results further confirm findings from stroke reviews based on published stroke epidemiological studies that show marked variation in stroke rates between countries with especially high rates in low-and middle-income countries [2, 3] .
During the nearly 25 years of GBD estimation, there have been significant advancements in the epidemiologic modeling and region/country specific reporting of causes of death (CODs) [4] . The validity of diagnosis of stroke as a COD depends on access to health facilities, local coding practices, availability of CT/MRI imaging, which is of particular importance when dividing the stroke estimates into ischemic stroke (IS) and hemorrhagic stroke (HS) [5, 6] . A key issue in assessing the stroke mortality burden is that varying proportions of unspecified CODs are stroke events that are coded inaccurately, and the handling of these codes may impact estimated stroke mortality and the associated estimations of stroke incidence and prevalence rates. The proportion of routine mortality codes that are unspecific has remained constant at 29-33% since the launch the GBD, representing the so-called 'garbage codes' (GCs), figure 1 [7] .
Every International Classification of Disease (ICD) code that is assigned to death but cannot be a specific underlying cause of death must be redistributed, and during this process, ambiguous codes are split to their likely specific cause. Ill-defined codes are codes that cannot be a cause of death, for example R54 (senility, ICD-10). Because these types of GCs are completely ambiguous in the process of CODs estimation, these events are assigned to all specific CODs. Intermediate codes are events coded secondary to a different underlying causes, such as I50 (heart failure, ICD-10). We assigned these events to any cause that pathologically can be underlying cause for this intermediate cause. CODs that can be related to different specific disease categories, for example I10 (hypertension, ICD-10), are assigned to any underlying CODs that pathological and will be directly due to this disorder.
The purpose of the current manuscript is to present the regional distribution of GCs and the impact on regional stroke mortality data for the GBD 2013.
Methodology
The methodology for the GBD 2013 estimates have been described previously [1] . In brief, all available mortality data were compiled and non-specific cause codes were redistributed based on literature review and statistical methods. The total for all causespecific deaths was fit to an envelope for all-cause mortality for 240 specific causes, including IS and HS.
Specific GCs that have effects on cerebrovascular disease are shown in figure 1 and by age in year 2005 in figure 2. Especially 'ill-defined codes', 'hypertension and atherosclerosis' and 'unspecific stroke' are major contributing codes. ICD codes (ICD-9 and ICD-10) that were used for definition of IS, HS and other GCs are shown in table 1 . GCs were redistributed to their specific COD codes (target codes) by age, sex, country and year. Target code reassignment was done one by one based on ICD classification and the pathology behind each GC by checking of multiple CODs and literature review.
We defined the pool of data as all mortality data coded to within the group's undefined codes, or the group's redistribution target codes for each country, year, age and sex. We then ran the following regression as described in Ahern et al. [8] .
TG crt = α = βU crt + γ r + θ r U crt + ε ct where TG crt : percentage of death data within a given undefined site code's data pool, which were coded to specific site groups, by country (c), year (t) and with countries categorized into regions (r)-: percentage of death data within given undefined site code's coded to undefined site code by country, year, region-fixed constant-: slope coefficient describing associated between and-: region-specific random intercept-: region-specific random slope-: normally-distributed error.
If the coefficient was positive and statistically significant at a p value <0.05 level the target group was dropped and the regression rerun. As an example, for the redistribution of the CODs, 'hypertension', 'chronic kidney disease due to hypertension' and 'hypertensive heart disease' were initially included, but for these causes there were not any significant coefficient, and they were consequently omitted.
Furthermore, target codes were dropped if the coefficient was positive and statistically significant. The regression was then repeated a third time. After running the regression 3 times, the yintercept was used as an estimate of an ideal, all-target, no undefined data pool. If there were multiple target groups, the y-intercepts for negative and statistically significant coefficients were scaled to sum 100%, and the proportions for the different target codes were used to redistribute the undefined codes to the target code. We ran these regressions on added whole data set (ICD-9 and ICD-10) for one country (or region) by age and sex. Separate regressions were run for each sex and for the following 3 age groups within each sex: 0-14, 15-49 and 50+ years.
Results
The redistribution of GCs to stroke and stroke subtypes varied markedly between regions, age and sex.
For 'unspecified stroke', almost all events in subjects aged <50 years are assigned to hemorrhagic stroke and subarachnoid hemorrhage (SAH); in the CODs estimation, these 2 types of hemorrhages are combined as HS. In subjects aged 70 years or more, mostly all 'unspecified stroke' deaths are assigned to IS, figure 3 . Redistribution of 'unspecified stroke' varied by region, as exemplified for men aged 50-69 years, figure 4 . In Eastern Europe, almost all unspecified stroke events are assigned to IS whereas the majority of unspecified stroke events in South East and Central Asia are assigned to ICH.
For 'hypertension' as a COD, the redistribution to target codes by age and sex on the global level is shown in figure 5 . In subjects aged less than 15 years, and in women aged 15-49 years, HS is the main target code. In men and in subjects aged 50 years or more, the majority of hypertensive deaths are assigned to ischemic heart disease and IS. The regional and global redistribution of deaths coded to hypertension to target codes as exemplified by women aged 50-69 years is shown in figure 6 . In Southern Sub-Saharan Africa, more than half of all hypertensive deaths were redistributed to intracranial hemorrhage. The highest proportion of hypertensive deaths assigned to IS occurred in Eastern Europe. Other GCs that are redistributed to stroke (ICD-10) are listed in table 1 , and the fractions of deaths that have been added to each of the categories of IS, HS, and SAH are listed in table 2 . The complete list of ICD 9 and ICD 10 codes for IS, HS, and associated GCs is provided in table 3. More than half of all IS fatalities and nearly half of all HS fatalities are derived from the redistribution of 'unspecified stroke'.
Discussion
The GBD provides a unique opportunity for estimating stroke mortality and the associated burden on a global level, applying a standardized methodology taking into account all other major CODs. A large proportion of stroke fatalities stems from the redistribution of especially 'unspecified stroke' and 'hypertension', as well as many other codes. 6 . Fraction of death coded due to hypertension assigned to the different target codes in females aged 50-69 years, regional level. Ideally, the global burden of stroke should be based on the 'gold standard' stroke epidemiology data; however, there is a shortage of such data from high-income countries and, especially, from low-and middle-income countries [3] . In the absence of ideal data, routine mortality statistics are used relying on the certifying person's ability to correctly assess and code what was the underlying cause of death. Previous studies from different countries have shown that the validity of stroke subtype diagnoses varies [5, 6, 9] . Whereas 'IS' and 'intracerebral hemorrhage' codes are often correct, maybe by requiring a detailed level of knowledge of the cause of the subjects' symptoms including access to scanning facilities, there is more uncertainty with regards to the validity of the diagnosis 'unspecified stroke' as this may be based on clinical signs alone without neuroimaging. The access to healthcare and imaging facilities varies between countries as well as between socioeconomic groups between and within countries and could impact death certification and coding practice.
In regions without routine mortality statistics, knowledge about stroke as a COD may be derived from results based on verbal autopsy [10] . There are several examples of such studies from different countries where assessment of stroke has been examined [11] [12] [13] . Differences in the development of disease algorithms could hamper the comparability, but represents a first step in increasing the knowledge of cerebrovascular diseases as a COD.
For countries with no data available, like some countries in North Africa, the Middle-East and large parts of Asia, the estimations are based on regional patterns and a full set of covariates that are available for all countries and for all years. Shortage on data causes uncertainty about the redistribution of GCs to target codes. As an example in this study, 'hypertension' was very differently redistributed to ischemic heart disease, IS and HS in Eastern Europe as compared to Central and Western Europe.
Studies have suggested that there are marked differences in the occurrence of different subtypes of stroke between European populations [14, 15] ; the extent to which the current redistribution is consistent for all countries within each region is beyond the scope of this publication. However, it is an example of how increasing knowledge of stroke epidemiology and advancements in the statistical methods for redistributing CGs may lead to improvements in the future GBD methodology. Future results from large-scale population-based studies on stroke incidence, mortality and fatality [16] will be essential for refining regional GBD estimates.
In conclusion, stroke mortality data in the GBD is derived from routine statistics and the redistribution of illdefined and other diagnostic codes, which cannot be considered as specific CODs. A large proportion of stroke fatalities are derived from the redistribution of 'unspecified stroke' and 'hypertension'. Regional differences are marked, which is supported by real-world data; however, future advancements in stroke certification, data collections and statistical analyses may improve the estimation of the stroke mortality burden.
